Latest Articles
My wife died of cancer after being misdiagnosed over the phone - we need answers not excuses - ManchesterWorld
My wife died of cancer after being misdiagnosed over the phone - we need answers not excuses ManchesterWorld
Published: Nov. 2, 2024, 5:09 p.m.
Ovarian Cancer Misdiagnosis Stories and What We Can Learn from Them - Healthline
Ovarian Cancer Misdiagnosis Stories and What We Can Learn from Them Healthline
Published: Nov. 1, 2024, 3:44 p.m.
Mum of three misdiagnosed by her GP over the phone dies just weeks later - The Mirror
Mum of three misdiagnosed by her GP over the phone dies just weeks later The Mirror
Published: Oct. 31, 2024, 9:47 p.m.
Young mum misdiagnosed in phone call dies three days after getting cancer prognosis - Daily Record
Young mum misdiagnosed in phone call dies three days after getting cancer prognosis Daily Record
Published: Oct. 31, 2024, 9:04 p.m.
Mum-of-three, 33, misdiagnosed by GP over phone call dies just weeks later - Manchester Evening News
Mum-of-three, 33, misdiagnosed by GP over phone call dies just weeks later Manchester Evening News
Published: Oct. 31, 2024, 4:11 p.m.
Over 80% of women have had their pain dismissed by a healthcare professional - MSN
Over 80% of women have had their pain dismissed by a healthcare professional MSN
Published: Oct. 28, 2024, 1:11 p.m.
‘Medical misogyny’ nightmare called out - news.com.au
‘Medical misogyny’ nightmare called out news.com.au
Published: Oct. 28, 2024, 12:18 p.m.
Women with Endometriosis Often Miss School and Work Due to Pain - Pain News Network
Women with Endometriosis Often Miss School and Work Due to Pain Pain News Network
Published: Oct. 28, 2024, 7:01 a.m.
HopeMed's Breakthrough in Endometriosis Treatment: A Promising Step Forward - Devdiscourse
HopeMed's Breakthrough in Endometriosis Treatment: A Promising Step Forward Devdiscourse
Published: Oct. 25, 2024, 5:14 a.m.
Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers - BioSpace
Merck’s KEYTRUDA® (pembrolizumab) Receives 30th Approval From European Commission With Two New Indications in Gynecologic Cancers BioSpace
Published: Oct. 24, 2024, 11:46 a.m.
Link copied to clipboard!